The Expression of the Beta Cell-Derived Autoimmune Ligand for the Killer Receptor Nkp46 Is Attenuated in Type 2 Diabetes

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Gur, Chamutal ^a,b,d   Enk, Jonatan ^a,d   Weitman, Efraim ^c   Bachar, Etty ^b   Suissa, Yaron ^c   Cohen, Guy ^d   Schyr, Rachel Ben Haroush ^b   Sabanay, Helena ^e   Horwitz, Elad ^a,d   Glaser, Benjamin ^b   Dor, Yuval ^c   Pribluda, Ariel ^e   Hanna, Jacob H ^e   Leibowitz, Gill ^b   Mandelboim, Ofer ^a,d  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c HEBREW UNIVERSITY   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^e WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; IN VIVO STUDY; INSULIN RELEASE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NATURAL KILLER CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; PSAMMOMYS OBESUS; RAT;

ANIMALS; ANTIGENS, LY; AUTOIMMUNITY; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION; GENE EXPRESSION REGULATION; INSULIN; INSULIN-SECRETING CELLS; LEPTIN; LIGANDS; MALE; MICE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; PROTEIN BINDING;

EID: 84883247068     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074033     Document Type: Article

References (27)

1. Seidel E, Glasner A, Mandelboim O (2012) Virus-mediated inhibition of natural cytotoxicity receptor recognition. Cell Mol Life Sci.
2. Stanietsky N, Mandelboim O, (2010) Paired NK cell receptors controlling NK cytotoxicity. FEBS Lett 584: 4895-4900.
3. Gazit R, Gruda R, Elboim M, Arnon TI, Katz G, et al. (2006) Lethal influenza infection in the absence of the natural killer cell receptor gene Ncr1. Nat Immunol 7: 517-523.
4. Pessino A, Sivori S, Bottino C, Malaspina A, Morelli L, et al. (1998) Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J Exp Med 188: 953-960.
5. Stern-Ginossar N, Mandelboim O, (2009) An integrated view of the regulation of NKG2D ligands. Immunology 128: 1-6.
6. Elias S, Mandelboim O (2012) Battle of the midgets: Innate microRNA Networking. RNA Biol 9.
7. Mandelboim O, Lieberman N, Lev M, Paul L, Arnon TI, et al. (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
8. Arnon TI, Achdout H, Lieberman N, Gazit R, Gonen-Gross T, et al. (2004) The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103: 664-672.
9. Gur C, Doron S, Kfir-Erenfeld S, Horwitz E, Abu-Tair L, et al. (2012) NKp46-mediated killing of human and mouse hepatic stellate cells attenuates liver fibrosis. Gut 61: 885-893.
10. Gur C, Enk J, Kassem SA, Suissa Y, Magenheim J, et al. (2011) Recognition and killing of human and murine pancreatic beta cells by the NK receptor NKp46. J Immunol 187: 3096-3103.
11. Gur C, Porgador A, Elboim M, Gazit R, Mizrahi S,et al. (2010) The activating receptor NKp46 is essential for the development of type 1 diabetes. Nat Immunol 11: 121-128.
12. Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, et al. (2009) NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J Clin Invest 119: 1251-1263.
13. Weir GC, Bonner-Weir S, (2013) Islet beta cell mass in diabetes and how it relates to function, birth, and death. Ann N Y Acad Sci 1281: 92-105.
14. Imai Y, Dobrian AD, Morris MA, Nadler JL (2013) Islet inflammation: a unifying target for diabetes treatment? Trends Endocrinol Metab.
15. Shapiro H, Shachar S, Sekler I, Hershfinkel M, Walker MD, (2005) Role of GPR40 in fatty acid action on the beta cell line INS-1E. Biochem Biophys Res Commun 335: 97-104.
16. Achdout H, Arnon TI, Markel G, Gonen-Gross T, Katz G, et al. (2003) Enhanced recognition of human NK receptors after influenza virus infection. J Immunol 171: 915-923.
17. Kaiser N, Cerasi E, Leibowitz G, (2012) Diet-Induced Diabetes in the Sand Rat (Psammomys obesus). Methods Mol Biol 933: 89-102.
18. Kaiser N, Nesher R, Donath MY, Fraenkel M, Behar V, et al. (2005) Psammomys obesus, a model for environment-gene interactions in type 2 diabetes. Diabetes 54Suppl 2: S137-144.
19. Leibowitz G, Yuli M, Donath MY, Nesher R, Melloul D, et al. (2001) beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes. Diabetes 50Suppl 1: S113-117.
20. Lovshin JA, Drucker DJ, (2009) Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol 5: 262-269.
21. Ogasawara K, Hamerman JA, Ehrlich LR, Bour-Jordan H, Santamaria P, et al. (2004) NKG2D blockade prevents autoimmune diabetes in NOD mice. Immunity 20: 757-767.
22. Satoh-Takayama N, Dumoutier L, Lesjean-Pottier S, Ribeiro VS, Mandelboim O, et al. (2009) The natural cytotoxicity receptor NKp46 is dispensable for IL-22-mediated innate intestinal immune defense against Citrobacter rodentium. J Immunol 183: 6579-6587.
23. Gold G, Gishizky ML, Grodsky GM, (1982) Evidence that glucose "marks" beta cells resulting in preferential release of newly synthesized insulin. Science 218: 56-58.
24. Tian Z, Sun R, Wei H, Gao B, (2002) Impaired natural killer (NK) cell activity in leptin receptor deficient mice: leptin as a critical regulator in NK cell development and activation. Biochem Biophys Res Commun 298: 297-302.
25. Grill V, Radtke M, Qvigstad E, Kollind M, Bjorklund A, (2009) Beneficial effects of K-ATP channel openers in diabetes: an update on mechanisms and clinical experiences. Diabetes Obes Metab 11Suppl 4: 143-148.
26. Ortqvist E, Bjork E, Wallensteen M, Ludvigsson J, Aman J, et al. (2004) Temporary preservation of beta-cell function by diazoxide treatment in childhood type 1 diabetes. Diabetes Care 27: 2191-2197.
27. Skak K, Gotfredsen CF, Lundsgaard D, Hansen JB, Sturis J, et al. (2004) Improved beta-cell survival and reduced insulitis in a type 1 diabetic rat model after treatment with a beta-cell-selective K(ATP) channel opener. Diabetes 53: 1089-1095.